New Smith & Sheridan Podcast Feed

We are pleased to announce that we are expanding our distribution to all the major directories, platforms, and apps, including Apple Podcasts, Google Podcasts, Spotify, Amazon Music, and YouTube. To facilitate this, we are discontinuing this subscription feed you are currently subscribed to. To access the new feed, log into your preferred player and search for "Smith and Sheridan on Biotech". Alternatively, simply go to https://smithandsheridan.eu/ and select "Listen Now". We would suggest unsubscribing from your original subscription to avoid any confusion. On the new feed you will find the latest episodes.
Listen on:
about

Disclaimer

The views, thoughts, and opinions expressed during the Smith & Sheridan podcast series belong solely to the individuals involved. Smith & Sheridan Ltd. is not responsible and does not verify for accuracy any of the information contained in the podcast series available to listeners. The primary purpose of this podcast series is to inform. This podcast series does not constitute investment advice, recommendations, or services. 
This podcast is available for private, non-commercial use only. You may not edit, modify, or redistribute this podcast without the express approval and knowledge of Smith & Sheridan Ltd. 
The developers of the Smith & Sheridan podcast series assume no liability for any activities in connection with this podcast or for the use of this podcast in connection with any other website, computer, or playing device.
Unless otherwise noted, our discussions are as of the date of their recording, we do not undertake any obligation to update any statements made in the podcasts as a result of new information, future events or otherwise.  

Episodes:

We publish one episode per week in three series per year: 
Mid-January to Mid-April | Mid-May to Mid-August | Mid-September to Mid-December.

Corporate Subscription:

Corporate Subscription Plans are available. Contact corporate@smithandsheridan.eu for details. 
Read more
featured episodes

Take a look at what's inside

Featured Episodes
2.7. ‘MetaMorphosys’ or how a big pivot paid off (kind of)
More Episodes
2.7. ‘MetaMorphosys’ or how a big pivot paid off (kind of)
2.6. Hereditary angioedema: Biotech innovation in action
2.5 NASH. What’s in a name? Mash and Nash both spell liver disease
2.4 When is a deal not a deal. Sanofi makes a big bet in AATD
2.3 Radiopharmaceuticals space heats up as BMS and Lilly join the fray
2.2 Recent Biotech Acquisitions. Done already, or more to come?
+ 10 more episodes
ama

Ask Me Anything with Smith & Sheridan on Biotech

Frequently Asked Questions

How do I listen to subscriber-exclusive podcasts and content?
How do I get in touch?
What is Supercast?